Annita Kolnagou - Concepedia

Author

Annita Kolnagou

Paphos General Hospital

Also Known As

A Kolnagou, Annita Kolnagou, George John Kontoghiorghes, Kolnagou, Annita

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Paphos General Hospital Cyprus Institute of Neurology and Genetics Cyprus Institute Archbishop Makarios III Hospital Larnaca College

About

Annita Kolnagou is an author at Paphos General Hospital specializing in medicine, hematology, and clinical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	384
2	Biochemistry	2	2	125
3	Engineering	1	1	52
4	Health Sciences	1	1	59
5	Public Health	1	1	79

Annita Kolnagou

Publications

699

Citations

H-Index

Page 1

	Year	Citations
The Role of Iron and Chelators on Infections in Iron Overload and Non Iron Loaded Conditions: Prospects for the Design of New Antimicrobial Therapies George J. Kontoghiorghes, Annita Kolnagou, Anna Skiada, Hemoglobin Microbial PathogensAntimicrobial ChemotherapyRedox BiologyDrug ResistanceAntimicrobial Therapy	2010	84
Low Serum Ferritin Levels are Misleading for Detecting Cardiac Iron Overload and Increase the Risk of Cardiomyopathy in Thalassemia Patients. The Importance of Cardiac Iron Overload Monitoring Using Magnetic Resonance Imaging T2 and T2* Annita Kolnagou, Charalambos Economides, Eleni Eracleous, Hemoglobin Chelation TherapyCardiac ComplicationsCardiomyopathyHeart FailureCardiovascular Disease	2006	79
Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2* Annita Kolnagou, Konstantinos Natsiopoulos, Marios Kleanthous, Toxicology Mechanisms and Methods Iron MetabolismSerum Ferritin LevelsIron DeficiencyExcess Storage IronMagnetic Resonance Imaging	2012	59
Long Term Comparative Studies in Thalassemia Patients Treated with Deferoxamine or a Deferoxamine/Deferiprone Combination. Identification of Effective Chelation Therapy Protocols Annita Kolnagou, Charalambos Economides, Eleni Eracleous, Hemoglobin ThrombosisTherapeutic Drug MonitoringHeart FailureEngineeringThalassemia Patients Treated	2008	52
Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy Annita Kolnagou, Marios Kleanthous, George J. Kontoghiorghes European Journal Of Haematology	2010	50
The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients Annita Kolnagou, Yiannis Michaelides, Christina Kontoghiorghe, Toxicology Mechanisms and Methods	2012	49
EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment Tammy Born, Christina Kontoghiorghe, Aspasia Spyrou, Toxicology Mechanisms and Methods Heart FailurePharmacotherapyMetronomic ChemotherapyCardiovascular ToxicityClinical Trials	2012	46
The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study Petros Kountouris, Ioanna Kousiappa, Thessalia Papasavva, Scientific Reports	2016	46
Effective Combination Therapy of Deferiprone and deferoxamine for the Rapid Clearance of Excess Cardiac IRON and the Prevention of Heart Disease in Thalassemia. The Protocol of the International Committee on Oral Chelators Annita Kolnagou, George J. Kontoghiorghes Hemoglobin	2006	44
Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption George J. Kontoghiorghes, Aspasia Spyrou, Annita Kolnagou Hemoglobin Thalassemia IntermediaIron MetabolismPharmacotherapyIron DeficiencyRedox Biology	2010	41

Page 1